BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/14/2017 3:13:08 AM | Browse: 1118 | Download: 1892
 |
Received |
|
2017-05-19 05:32 |
|
Peer-Review Started |
|
2017-05-19 13:15 |
|
To Make the First Decision |
|
2017-06-22 00:39 |
|
Return for Revision |
|
2017-06-23 10:36 |
|
Revised |
|
2017-07-05 08:20 |
|
Second Decision |
|
2017-08-02 00:36 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2017-08-08 05:57 |
|
Articles in Press |
|
2017-08-08 05:57 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2017-09-04 11:02 |
|
Publish the Manuscript Online |
|
2017-09-14 03:13 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Access to biologicals in Crohn’s disease in ten European countries
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Márta Péntek, Péter L Lakatos, Talitha Oorsprong, László Gulácsi, Milena Pavlova, Wim Groot, Fanni Rencz, Valentin Brodszly, Petra Baji and Crohn’s Disease Research Group |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| ÚNKP-16-4/BCE-0025 New National Excellence Program of the Ministry of Human Capacities (Hungary) |
|
|
| Corresponding Author |
László Gulácsi, PhD, Professor, Department of Health Economics, Corvinus University of Budapest, Fővám tér 8, Budapest 1093, Hungary. laszlo.gulacsi@uni-corvinus.hu |
| Key Words |
Crohn’s disease; Biological therapy; Access; Inequality; Europe |
| Core Tip |
We carried out a questionnaire survey with gastroenterologists combined with desk research to analyze access to biologicals for Crohn’s disease in ten European countries. Regarding availability, reimbursement criteria were the least restrictive in Sweden and Germany, and the most restrictive in Hungary, Poland and Slovakia. Between countries, the annual cost of biological treatments differed 1.6-3.3-fold. Treatments were the most affordable in Sweden and the least affordable in Hungary and Romania. The number of patients on biologicals per 100000 population was strongly correlated with gross domestic product, although substantial differences were found in the uptake among countries with similar economic development. |
| Publish Date |
2017-09-14 03:13 |
| Citation |
Péntek M, Lakatos PL, Oorsprong T, Gulácsi L, Pavlova M, Groot W, Rencz F, Brodszky V, Baji P; Crohn’s Disease Research Group. Access to biologicals in Crohn’s disease in ten European countries. World J Gastroenterol 2017; 23(34): 6294-6305 |
| URL |
http://www.wjgnet.com/1007-9327/full/v23/i34/6294.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v23.i34.6294 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
